Author:
Galsky M.D.,Camacho L.H.,Chiorean E.G.,Mulkerin D.,Hong D.S.,Oh W.K.,Bajorin D.F.
Reference17 articles.
1. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug;Kelland;Cancer Res,1993
2. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin;Twentyman;Cancer Res,1992
3. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines;Mellish;Int J Cancer,1995
4. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters;Samimi;Cancer Chemother Pharmacol,2006
5. Phase I study of oral JM216 given twice daily;Beale;Cancer Chemother Pharmacol,1998
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献